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ABSTRACT
Objective. Enthesitis represents a char-
acteristic features of spondyloarthritis 
(SpA) and, in the context of the early 
management of the disease, its reliable 
assessment has emerged as a central is-
sue. Musculoskeletal ultrasonography 
(US) has proven to be of value in the 
assessment of peripheral entheses. Our 
aim was to systematically review the lit-
erature from 2010 to 2013 in order to 
summarise the evidence on the evalua-
tion of entheses by US in patients with 
diagnosed or suspected SpA.
Methods. PubMed and Embase were 
searched developing a search strategy 
based on terms related to SpA and US. 
The target population were patients with 
SpA or suspected SpA, the intervention 
was entheseal US, the outcomes were 
the prevalence of US abnormalities, 
the reliability, the diagnostic accuracy, 
the sensitivity to change. The possible 
comparators were clinical evaluation 
and other imaging techniques. Cohort 
studies (cross-sectional or longitudi-
nal), case-control studies, diagnostic 
accuracy studies, systematic literature 
reviews and meta-analyses were eligi-
ble for inclusion.
Results. Out of 3368 retrieved refer-
ences, 34 papers were finally included. 
22 of which reported information on 
the prevalence of US findings, yielding 
highly variable results. US was suffi-
ciently reliable, as reported in 6 papers. 
A minority of studies reported data on 
sensitivity to change, which was good, 
and on the application of US for differ-
ential diagnosis and diagnosis of SpA, 
thus demonstrating the value of US also 
in this context.
Conclusion. US confirms its validity and 
reliability in the assessment of entheseal 
involvement in patients with SpA. Fur-
ther application in the help of diagnosis 
will be provided by future research.
Introduction 
Inflammation at the entheses is a typi-
cal pathological feature of spondy-
loarthritides (SpA) and its presence 
characterises all disease subtypes, in-
cluding ankylosing spondylitis (AS) 
and psoriatic arthritis (PsA) (1). Periph-
eral entheses are mainly composed of 
fibrocartilage, especially at the lower 
limbs. These structures have the role of 
distributing on large surfaces high lev-
els of mechanical stress, and they can 
be surrounded by bursae and fat pads, 
which are meant to reduce attrition (2). 
At the level of enthesis, therefore, sev-
eral structures play the same functional 
role and can potentially be involved as 
a whole in the pathologic process as an 
entheseal organ (3). In patients with 
SpA, entheseal involvement can oc-
cur early in the disease course and may 
constitute its prevalent manifestation, 
often involving multiple sites (4). The 
assessment of entheses for diagnostic 
and follow-up purposes has commonly 
been based on clinical examination, 
since conventional radiography could 
mainly identify bony changes such as 
erosions and new bone formation, oc-
curring later in the disease (5).
New imaging techniques, ultrasono-
graphy (US) and magnetic resonance 
imaging (MRI) in particular, have been 
applied for the assessment of peripheral 
joint involvement in SpA. A number of 
studies have investigated the potential 
application of US in joints of patients 
with SpA (6-8). Nevertheless, specific 
features driving differential diagnosis 
were not consistently found, with in-
flammatory and structural alterations 
being similar to those reported in other 
inflammatory arthritides. Entheseal 
involvement instead represents a spe-
cific feature of SpA and its assessment 
by US has proven to be more sensi-
tive than clinical examination  (9). The 
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use of US in this field has some ad-
vantages over MRI, which has shown 
some limitations in the assessment of 
peripheral entheses (10); it does not al-
low the evaluation of multiple sites and 
carries some relevant costs. US, on the 
other hand, allows the interactive and 
dynamic evaluation of multiple sites 
without the use of ionising radiation. 
It has shown reliability in the assess-
ment of peripheral entheses, with good 
correlation with clinical and laboratory 
measures of disease activity indicating 
validity (11). US of the entheses can 
detect both structural abnormalities, 
such as changes in the US texture of the 
tendon, increased thickness, calcifica-
tions a the insertion or in the context of 
the tendon, bone erosions, and signs of 
hypervascularisation suggesting active 
inflammation, detected by Doppler and 
power Doppler (PD) in particular (12). 
Entheseal US has also proven to be re-
sponsive to change after the initiation 
of treatment (13). For these reasons, US 
has been proposed in the diagnosis and 
the follow-up of entheseal involvement 
in patients with SpA.
A consensus on the US definition of en-
thesitis has been reached only recently. 
The core elementary lesions of US-
detected enthesitis include hypoecho-
genicity, increased thickness of the 
tendon at the insertion, calcifications, 
enthesophytes, erosions, and Doppler 
signal. The intra-reader reliability on 
these findings has shown however to 
be highly variable, with kappa ranging 
from 0.24 for the detection of entheso-
phytes to 0.64 for the evaluation of the 
presence of entheseal PD. Similarly, 
also inter-reader realibility varied de-
pending on the lesion  (14).
In 2011, a systematic literature review 
addressed the issue of enthesitis defined 
by US, evaluating literature up to 2010 
with the aim of describing several US 
definitions of enthesitis and examining 
their metrologic properties (15). The re-
view included 48 articles, published up 
to 2010, of which only 22 applied PD. 
Information on validity was available 
for 21 studies, 14 papers reported reli-
ability and responsiveness was evalu-
ated in 9 studies. Scoring systems were 
applied in only 3 studies. Since 2010, 
the application of US in the field of SpA 
has increased. Moreover, scoring sys-
tems focusing on entheses such as the 
Madrid sonographic enthesitis index 
(MASEI) and the Glasgow Ultrasound 
Enthesitis Scoring System (GUESS) 
have been more frequently applied in 
research settings (16, 17). It seemed, 
therefore, timely to review the literature 
on this topic in the last 4 years, also in 
the light of the new definition of US en-
thesitis. For this purpose, we systemati-
cally reviewed the literature and report-
ed qualitatively the available evidence 
emerging in the last four years. 
Methods 
A search strategy based on terms re-
lated to SpA and US was developed 
(Table I). We searched MEDLINE 
(PubMed) and Embase up to March 9th 
2014. The references of the relevant 
studies were also hand searched to look 
for additional references. The search 
was limited to humans and adults, was 
made by one author and checked by a 
second author. Data were extracted us-
ing a standardised form.
The target population were patients 
with diagnosed or suspected SpA. This 
included AS, PsA, undifferentiated 
SpA, reactive arthritis, arthritis related 
to inflammatory bowel diseases (IBD). 
The intervention was US of entheses, 
with several possible comparators: 
clinical evaluation or other imaging 
techniques (MRI or radiography). The 
outcomes of interest were the preva-
lence of US abnormalities, the diag-
Table I. Search strategy.
PubMed #1 Spondylitis, Ankylosing [Mesh] 
 #2 “bechterew disease” 
 #3 “Marie Struempell” 
 #4 (ankylos* spondyl*)
 #5 Spondyloarthritis [Mesh]
 #6 (spondyl*)
 #7 Arthritis, Reactive [Mesh]
 #8  “reactive arthritis” 
 #9 (reiter* syndrome)
 #10 (reiter*disease) 
 #11 OR 1-10
 #12 Arthritis, Psoriatic [Mesh] 
 #13 (arthri* psoria*) 
 #14 (arthro* psoria*)
 #15 OR 12-14
 #16 (enthes*)
 #17 Inflammatory Bowel Diseases [Mesh] 
 #18 Arthritis [Mesh]
 #19 #17 AND #18
 #20 (“Crohn” OR (enteropath*) NEXT (arthri* OR arthrop*))
 #21 #19 OR #20
 #22 #11 OR # 16 OR #21
 #23 “Ultrasonography”[Mesh] 
 #24 “Ultrasonography, Doppler”[Mesh] 
 #25 (ultraso*)
 #26 “Doppler” 
 #28 OR 23-27
 #29 #22 AND #28
EMBASE #1 ankylosing AND (‘spondylitis’/de OR spondylitis) AND [humans]/lim AND 
 [embase]/lim
 #2 ‘spondyloarthropathy’/exp OR spondyloarthropathy AND [humans]/lim AND 
 [embase]/lim
 #3 bechterew AND (‘disease’/exp OR disease) AND [humans]/lim AND [embase]/lim
 #4 reactive AND (‘arthritis’/exp OR arthritis) AND [humans]/lim AND [embase]/lim
 #5 reiter AND (‘syndrome’/exp OR syndrome) AND [humans]/lim AND [embase]/lim
 #6 psoriatic AND (‘arthritis’/exp OR arthritis) AND [humans]/lim AND [embase]/lim
 #7 ‘enthesitis’/exp OR enthesitis AND [humans]/lim AND [embase]/lim
 #8 inflammatory AND (‘bowel’/exp OR bowel) AND (‘disease’/exp OR disease) AND 
(‘arthritis’/exp OR arthritis) AND [humans]/lim AND [embase]/lim
 #9 #1 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9
 #10 ‘ultrasonography’/exp OR ultrasonography AND [humans]/lim AND [embase]/lim
 #11 doppler AND [humans]/lim AND [embase]/lim
 #12 #11 OR #12
 #13 #9 AND #12
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nostic accuracy of US, the reliability 
of the technique, the responsiveness to 
change. Cohort studies (cross-sectional 
or longitudinal), case-control studies, 
diagnostic accuracy studies, systematic 
literature reviews and meta-analysis 
were eligible for inclusion.
Results
The search initially retrieved 3368 
papers. Of these, 34 studies were fi-
nally included. The selection process is 
shown in Figure 1. When differentiat-
ing studies according to the population 
examined, 4 of the included studies fo-
cused on AS (17-21), 7 studies involved 
patients with psoriatic arthritis (PsA) 
(22-28), 13 were based on mixed popu-
lations or populations of undifferentiat-
ed SpA (29-41), with a single study fo-
cusing on the SAPHO syndrome (42). 
A total of 12 studies involved patients 
without a definite diagnosis of SpA, but 
included subgroups with suspected di-
agnosis or at risk of developing SpA; 
in particular, 10 studies enrolled pa-
tients with psoriasis in the absence of 
diagnosed arthropathy (24, 25, 28, 43-
49), 1 patient with IBD (50) and only 
one study on consecutive patients with 
suspected new-onset SpA (51). When 
examining the technique of application 
of US, 24 studies applied PD, and one 
study investigated sonoelastography. 
Two studies evaluated the use of three-
dimensional (3D) US for the study of 
entheses and only one study examined 
the application of contrast-enhanced 
US. Scoring methods were applied in 
12 studies, in particular MASEI in 4 
studies, and GUESS in 5 studies. Most 
of the studies had a cross-sectional de-
sign, while 4 provided follow-up data. 
The main characteristics of the included 
studies and their results are reported in 
Tables II–V.
Prevalence of entheseal US 
abnormalitites
The prevalence of US abnormalities 
was reported in 21 studies. In patients 
with AS, the most common lesion, as 
reported by a single study (18), was 
entesophytes, present in 31.7% of in-
volved sites. The same study reports a 
lower prevalence of entheseal PD (6%). 
Scoring systems were not applied in this 
population.
In patients with PsA, PD is reported in 
up to 40.2% of cases, the same study 
reports at least a single entheseal ab-
normality detected by GS in all patients 
(26), consistent with a previous study 
reporting US signs of enthesopathy in 
98.3% of PsA patients (28). The mean 
MASEI in this group of patients ranged 
from 13 to 18.5 (24, 28).
Studies examining mixed populations 
reported highly variable prevalence of 
US-detectable enthesopathy, depend-
ing on the region of interest and on the 
features of the population. Overall, the 
prevalence of enthesopathy ranged from 
100% at the elbows in symptomatic pa-
tients (39) to 40.5% in the trochanteric 
entheses of patients with PsA (33), while 
studies examining multiple sites report-
ed prevalences ranged from 60.8 to 76% 
(34,37). Entesophytes were reported in 
95% of patients (33). Bone erosions at 
the tendon insertion were seen in 7.4% 
to 26.3% of patients (29, 30). The preva-
lence of entheseal PD ranged from 1% 
in the trochanteric region to 56% seen 
in symptomatic Achilles tendon. In two 
studies the MASEI was applied, with 
a mean value MASEI of 23.36 (11.40) 
(31).
Validity, reliability, sensitivity 
to change
A total of 6 studies correlated the re-
sults of entheseal US with relevant 
clinical and laboratory variables. In 
patients with AS, the presence of en-
theseal PD was significantly related 
with clinimetric measures of disease 
activity (19). Similarly, in patients with 
PsA, US findings were correlated with 
clinical assessment (22), although in 
one study the GUESS and the presence 
of PD did not correlate with MASEI, 
PASI or clinical indexes (27). In pa-
tients with SpA, the presence of ero-
sions was significantly related to acute 
phase reactants and clinical measures of 
disease activity at the level of Achilles 
tendon enthesis (30), while at the knee 
the agreement between US and clinical 
assessment was poor (37).
The reproducibility of entheseal US was 
examined in 6 studies, testing the intra 
and inter-reader reliability (22, 23, 30, 
35, 43, 50). The overall intra- and inter-
reader reliabilities were good for both 
GS and PD alterations, and were also 
shown to be good for the assessment of 
bone erosions. The reproducibility was 
not tested in AS patients, but only in the 
remaining populations. Also, the repro-
ducibility of 3D US proved to be good 
(30). 
Sensitivity to change was tested in 2 
studies. GS signs of enthesitis have 
shown to decrease along with clinical 
parameters of disease activity in PsA 
(23), while a single study confirmed 
the ability of CEUS to present different 
changes in patients stopping and then 
re-starting non-steroidal anti-inflam-
matory drugs (NSAIDs) (36).
Fig. 1. Flow-chart 
showing the selection 
process
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Utility of US for diagnosis
Only a few studies specifically ad-
dressed the issue of the additional value 
of entheseal US for diagnostic purposes.
In the context of AS, a single study ex-
amined the diagnostic accuracy of US 
for the diagnosis of enthesopathy, using 
conventional radiography as reference 
standard. US achieved high values of 
sensitivity (between 0.95 and 1), while 
specificity was lower, as a likely conse-
quence of the low sensitivity of radio-
graphs in detecting soft tissue abnor-
malities (20).
In general, many studies describe a 
higher frequency of US-detectable en-
theseal abnormalities in patients with 
PsA compared to healthy controls; in 
the setting of patients with psoriasis 
those with PsA more frequently had 
US abnormalities compared to those 
without arthropathy. In particular, us-
ing a cut-off of 20 for the MASEI, 
considering clinical diagnosis as refer-
ence standard, PsA could be diagnosed 
with a sensitivity of 0.3 and a specific-
ity of 0.89 (24), with a positive LR  of 
2.63 to differentiate PsA from psoriasis 
without joint involvement. Moreover, a 
study investigated the use of US of the 
entheses to help the differential diag-
nosis between PsA and fibromyalgia. 
In this setting, entheseal abnormalities 
were seen more frequently in PsA, and 
bone erosions were seen exclusively in 
this group of patients.
However, only one study applied enthe-
seal US in a setting fully reproducing 
clinical practice. Consecutive patients 
with clinical suspicion of SpA were 
enrolled and the diagnostic accuracy 
of US to detect SpA was tested against 
clinical diagnosis after a follow-up of 
two years (51). The presence of at least 
one site showing PD had a sensitivity 
of 0.76, a specificity of 0.81, a positive 
likelihood ratio (LR) of 4.1 and a nega-
tive LR of 0.3 for the diagnosis of SpA.
A number of studies have investigated 
the utility of US to detect subclinical 
enthesitis in populations at risk of de-
veloping SpA. In particular, 10 studies 
(24, 25, 28, 43-49) included patients 
with psoriasis, without a definite di-
agnosis of PsA. The result that seems 
to consistently emerge through the 
studies is that of a higher prevalence 
of subclinical enthesitis in patients 
with psoriasis compared to healthy 
controls, although patients with PsA 
still show US entheseal alterations 
more frequently and to a greater ex-
tent. Moreover, nail involvement was 
associated with subclinical entheseal 
involvement (43). A single study ex-
amined the prognostic potential of US 
in identifying psoriatic patients at risk 
of development of PsA: in this context 
baseline quadricipital tendon thickness 
predicted a subsequent development of 
PsA. In addition, this subgroup had a 
higher median baseline GUESS score 
(46). In the only study focusing on pa-
tients with IBD, a prevalence of enthe-
seal abnormalities in 92.6% of patients 
is reported, and PD was seen in 5% of 
entheses, while entheseal PD was not 
seen in controls (50).
Discussion
With more effective treatments and 
treatment strategies becoming availa-
ble for the management of SpA, specif-
ic issues such as timely diagnosis, eval-
uation of subclinical diseases, monitor-
ing of treatment effect have emerged as 
central issues in the care of SpA (52). 
While for axial involvement MRI has 
emerged as the reference technique, 
despite some possible limitations (53), 
and has also been  included in the clas-
sification criteria (54), for peripheral 
involvement and entheseal involve-
ment in particular US has emerged as a 
feasible, easily accessible and reliable 
technique (55). For the assessment of 
Table II.  Included studies – ankylosing spondylitis. 
Sudy Population  Region of interest US equipment Outcome Results
Spadaro A 36 AS Extensor of the ESAOTE MyLab 70  Prevalence of entheseal enthesophytes 31.7%
2011 (18)  forearm, gluteus, 6-18 MHz  abnormalities calcifications 33.7%
  quadricipital tendon,  GS and PD  thickening 29.8%
  patellar  tendon   hypo-echogenicity 26.6% 
  (proximal and distal),    Erosions 9.7%
  Achilles tendon,    PD 6%
  plantar fascia 
Hamdi W 60 AS  Quadricipital tendon, Philips HD 11 Correlation of US  with PD  score significantly correlated with VAS pain,
2011 (19)  patellar tendon GS and PD clinical findings  BASDAI, BASFI, and ASQoL
  (proximal and distal), 
  Achilles tendon, 
  plantar fascia 
Hamdi W 60 AS Quadricipital tendon,  Philips HD11 Diagnostic accuracy of US Erosions: Se 100% Sp 20% PPV 93.22 NPV 100
2013 (20)  patellar tendon 15 MHz compared to radiography for  Thickening:  Se 95.5% Sp 13.3% PPV 76.7 NPV 100
  (proximal and distal),  GS the diagnosis on entesopathy New bone formation: Se 96.7% Sp 6.9% PPV 52.63 NPV 66.6
  Achilles tendon and 
  plantar fascia
  erosion, thickness, and 
  new bone formation 
Turan A  41 AS Achilles tendon Sonoelesatography Association between  The distal third of the Achilles tendons was the most
2013 (21) 32 HC enthesis Hi vision preirus elastography and conventional frequently affected region in AS, while the central part in HC 
   Hitachi US Softening detected by sonoelastography in the distal third  
     was associated with enthesopathy  and tendinous enlargement  
     on conventional US (p=0.07)
AS: ankylosing spondylitis; HC: healthy controls; GS: grey scale; PD: power Doppler; TNFi: TNF-α inhibitors; US: ultrasonography; CRP: C-reactive protein; ESR: erythrosedi-
mentation rate; Se: sensitivity; Sp: specificity; PPV: positive predictive value; NPV: negative predictive value.
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entheses in particular, the availability 
of higher frequency probes has allowed 
the diffusion of US at this level with a 
more reliable assessment.
In this review, the latest applications of 
US in the assessment of entheseal in-
volvement in adult patients with SpA 
were examined. The review did not 
focus on the issue of paediatric rheu-
matology, about which the information 
is more limited (56), and for which a 
specific search should be performed. 
In this specific field, the absence of a 
single definition of entheseal US in-
volvement has represented a limitation. 
In fact, the US features described in 
the included papers varied consistent-
ly, leading to a relevant heterogeneity 
across studies, with studies evaluating 
in different combinations increased 
thickness, reduced echogenicity, new 
bone formation, erosions and PD. The 
variability seen in the results concern-
ing the prevalence of US abnormalities 
might therefore be due to different defi-
nitions adopted, beside differences in 
the recruited populations.
Table III. Included studies – psoriatic arthritis. 
Study Population  Region of interest US equipment Outcome Results
Freeston J.E.  42 early PsA Common extensors Philips HDI 5000 Agreement between clinical Agreement on the presence of activity: 34% 
2012 (22) 10 HC of the forearm 12-5 MHz examination and US (GS >1 and Agreement on the absence of activity: 90.7%
  Patellar tendon 15-7 MHz PD >0) on the presence of active  Subclinical enthesitis 4%
  (distal insertion) GS score (0-3): enthesitis Intra-reader reliability: GS 0.73 (0.6-0.86); 
  Achilles tendon composite score of Intra-reader reliability PD 0.91 (0.85-0.98)
  Plantar fascia tendon/aponeurosis 
   thickening and 
   hypoechogenicity 
   PD (0-3)
Gutierrez M. 16 PsA 3 articular targets: ESAOTE MyLab 70 Development of a preliminary PD Median change from9 (4-12) at baseline to 3 (1-5)  
2012 (23) starting TNFi joints, tendons, 6-18 MHz score to monitor PsA at the end of the follow-up (p=0.0001)
 Involvement  entheses PD  All measures were sensitive to change
 of at least 2 2 dermatological  Sensitivity to change Inter-reader reliability: joints  0.787, tendon 0.844, 
 articulations targets: skin and  Intra and inter-reader reliability enthesis 0.895, skin 0.945, nail 0.665 
 and 1 skin/nail nail   Intra-reader reliability: joint 0.977, tendon 0.986, 
 target. One    enthesis 0.966, skin 0.904, nail  0.812
 region was 
 selected for 
 the follow-up
 8 weeks of 
 follow-up 
Eder L.  55 PsA Plantar fascia ESAOTE MyLab Comparing entheseal abnormalities Overall median MASEI: PsA 13,  psoriasis 6,
2014 (24) 66 psoriasis Achilles tendon 6–18 MHz between PsA, psoriasis and HC HC 3.5 (p<0.0001) 
 without PsA Patellar tendon GS and PD  MASEI inflammatory: PsA 6, psoriasis 2,
 60 healthy (distal and proximal)  Performance of MASEI in  HC 1 (p<0.0001)
 controls Quadricipital tendon  classifying patients as PsA MASEI damage: PsA.5, psoriasis 4, HC 3 (p<0.0010)
  Brachial triceps tendon   At least 1 inflammatory abnormality in 90%
     PsA patients, 72% psoriasis, 48.3% HC  (p<0.0001)
  Evaluation of: erosions,    MASEI≥ 20: Se 30% psoriasis vs. PsA, 30% HC vs. PsA
  calcifications, tendon   Sp 95% HC vs. PsA, 89% psoriasis vs. PsA 
  structure, tendon   LR+:  2.63 psoriasis vs. PsA, 5.8 HC vs. PsA 
  lesion, bursa, PD
  MASEI 
Farouk H.M. 30 PsA Achilles tendon ESAOTE MyLab 70 Entheseal US in the preclinical Entheseal abnormalities not significantly different 
2010 (25) 30 psoriasis  9–11 MHz diagnosis of PsA between groups 
   GS and PD  33.3% psoriasis, 46.7% PsA (p>0.05)
Marchesoni A.  30 PsA  14 entheses GS and PD Prevalence of PD at entheses in At least 1 abnormality in 100% of PSA and 80% of 
2012 (26) 30 FM   PsA and FM FM (p=0.01)
     Inflammatory abnormalities in 70% of PsA and 23%   
     of FM (p=0.001)
     Erosions seen only in PsA
     3 ore more alterations had the best discriminative 
     cut-off between the diseases
Bandinelli F. 92 early PsA GUESS lower limbs ESAOTE MyLab 70 Prevalence of US abnormalities and All patients had a  GUESS>1 
2013 (27)  Quadricipital, patellar, 15 MHz correlation with clinical features 40.2% of patients had PD 
  achilles tendons PD and GS  clinical  involvement in 29.3% 
  and plantar fascia   GUESS and PD did not correlate with MASEI,    
     PASI and clinical variables
Eder L. 79 psoriasis  patella tendon ESAOTE MyLab 70 GUESS, MASEI and prevalence of Enthesopathy in 98.3% of PsA patients, 97.5%
2012 (28) 59 PsA (proximal and distal 6-18 MHz US abnormalities in the three groups of patients with psoriasis  and 86.7% of HC
 60 HC  insertion),   Mean (sd) GUESS: PsA 8.9 (4.6), psoriasis 5.6 (3.5),  
  Achilles tendon,   HC 4.4 (3.9),  p<0.001,  
  plantar fascia,    Mean (sd) MASEI: PsA 18.5 (3) psoriasis 9.9 (7.4), 
  triceps tendon   HC 7.7 (9.2), p<0.001 
  MASEI
  GUESS 
     
PsA: psoriatic arthritis; HC: healthy controls; GS: grey scale; PD: power Doppler; TNFi: TNFα inhibitors; US: ultrasonography; CRP: C-reactive protein; ESR: erythrosedimentation 
rate; Se: sensitivity; Sp: specificity; LR: likelihood ratio, FM: fibromyalgia; MASEI: Madrid Sonographic Enthesitis Index; GUESS: Glasgow Ultrasound Enthesitis Scoring System.
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Despite some differences in defining 
enthesitis, a larger proportion of stud-
ies included PD assessment, compared 
to the 2011 systematic review, likely 
due to a greater diffusion of this tech-
nique (15). Moreover, the use of scor-
ing methods has become more com-
mon in research settings for the evalu-
ation of enthesitis, with several reports 
that support in particular the validity of 
GUESS and MASEI in the field of di-
agnosis and monitoring of SpA.
Examining study design, most of the 
studies were cross-sectional and their 
main aim was describing the prevalence 
Table IV. Application of entheseal US in patients with potential subclinical disease. 
Study Population  Region of interest US equipment Outcome Results
Ash Z. 46 psoriasis Achilles tendon, GE Logiq 9 and Prevalence of subclinical NAPSI significantly related to inflammation (rho=0.45, 
2012 (43) without PsA plantar fascia,  Logiq 5 enthesitis in psoriatic patients p=0.005) and chronicity scores (rho=0.35, p=0.05)
 (31 with nail quadricipital tendon, 9-14 MHz with nail involvement Inter-reader reliability: ICC 0.91-0.93 (0.79, 0.97) for 
 involvement) patellar tendon GS and PD Inter-reader reliability GS, 0.74-0.95 (0.45,0.98) for PD, 0.89-0.93 (0.76, 0.98) 
 21 HC  (proximal and distal)   for chronicity scores, overall score 0.92-0.95 (0.81, 0.98
Bandinelli F. 81 IBD GUESS GE Logiq 5 Prevalence of US abnormalities 92.6% of pts at least one alteration:
2011 (50) 40 HC  10 MHz Intra- and inter-reader reliabilities  81.5% increased thickness  
    GS and PD  67.9% entesophytes 
     27.1% bursitis 
     16.1% erosions 
     PD 16%
     In controls: 5% had entesophytes, no patient had PD
     Mean (sd) GUESS: 5.1 (3.5) in patients
     Intra-reader reliability ICC 0.99 (0.98,1)
     Inter-reader reliability:  ICC 0.97 (0.9, 0.99)
D’Agostino 118 with Plantar fascia ESAOTE Technos Diagnostic accuracy of PD 75% ofsubjects hads at least one abnormality 
M.A. 2011 (51) suspected  Achilles tendon MPX in the diagnosis of SpA  Abnormal enthesis: 32% in SpA vs. 26% in
 SpA Ptellar tendon  Reference standard: non-SpA (p<0.01) 
  (proximal)  rheumatologic diagnosis at At least 1 abnormal enthesis: 86% in SpA  vs. 75%
  Quadricipital tendon  2 years  in non-SpA (p=0.003)
  Gluteus medius   Achilles tendon: 43% in SpA vs. 33% in non-SpA (p=0.01)
   Common extensor   Lateral epicondyle: 37% in SpA vs. 28% in non-SpA 
  and flexor of the   (p=0.03) 
  forearm    At least 1PD psotive enthesis: 76% in SpA vs. 47% in 
     non-SpA (p<0.0001)
     At least 1 PD enthesis: Se 76.5 (76.3,76.5), Sp 81.2  
     (81.1, 81.4)
     LR+ 4.1 (3.5, 4.7), LR- 0.3 (0.2, 0.8)
     OR 14.8 (5.3, 37.2) (p=0.003)
De Simone 52 psoriatic All joints and tendons Toshiba Aplio XV Prevalence of US abnormalities  GS abnormalities: 36/52 patients 
2011 (44)  patients with of fingers and toes 5–12 MHz  PD abnormalities: 29/52 patients 
 pain at fingers  GS and PD  No GS abnormalities in controls, one patient showed PD 
 of joints 50 
 asymptomatic 
 patients with 
 psoriasis   
Naredo E. 162 patients 36 joints GE Logiq 9 Prevalence of entheseal Entheseal PD 7.4% psoriasis patients vs. 0% in HC 
2011(45) with psoriasis 18 entheses 8-14 MHz abnormalities (p=0.05) 
 without PsA 22 tendons GS and PD  OR of psoriasis over enthesopathy 2.6 
 60 HC  
Tinazzi I. 30 patients GUESS  GE Logiq 5 Predictive value of GUESS Baseline GUESS of patients who developed PsA  was
2011 (46)  with psoriasis  ALT HDI 3000 over the development of PsA  significantly higher  (mean 9.54±2.02 vs. 6.61±3.60,
 without PsA  10-15 MHz  p=0.0127) 
 followed for  GS and PD  Baseline thickness of the quadricipital tendon was an 
 3.5 years    independent predictor of the development of PsA
Aydin S. 42 psoriasis Lower limb entheses GS and PD  Prevalence of entheseal PD in Significantly higher scores in psoriasis than HC
2013 (47) 58 PsA  (inflammatory and  psoriasis compared to PsA (inflammation p<0.0001, chronicity p=0.02, total US
 23 HC  chronic features)  and HC scores p<0.0001). PsA patients had higher enthesopathy  
     scores than patients with psoriasis (inflammation p=0.04,  
     chronicity p=0.02) and HC (inflammation p<0.0001, 
     chronicity p=0.003)
     In non-symptomatic entheses: PsA higher PD scores than  
     psoriasis patients (p=0.003). PD was more frequently in  
     PsA (21/58, 36.2%) than psoriasis (4/42, 9.5%; p=0.002) 
Aydin S. 86 psoriasis Nail and distal -  Linkage between nail involvement Thickened tendon in nail involvement vs normal nail:
2012  (48) 20 HC  extensor of the  and extensor enthesopathy Psoriasis: 38 vs. 16%, p=0.03 
  finger enthesis     PsA 47 vs. 19%, p=0.008 
Gutierrez M. 45 psoriasis GUESS  GS and PD Prevalence of subclinical Psoriasis: 32.9% GS abnormalities, 0.9% PD
2011 (49) 45 HC    entheseal involvement  HC: 8.4% GS abnormalities, 0% PD
AS: ankylosing spondylitis; PsA: psoriatic arthritis; HC: healthy controls; GS: grey scale; PD: power Doppler; TNFi: TNF-α inhibitors; US: ultrasonography; CRP: C-reactive 
protein; ESR: erythrosedimentation rate; ICC: interclass correlation; GUESS: Glasgow Ultrasound Enthesitis Scoring System; IBD: inflammatory bowel disease, NAPSI: Nail 
Psoriasis Severity Index.
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Table V. Included studies – SpA and mixed populations. 
Study Population  Region of interest US equipment Outcome Results
Aydin S. 19 SpA Achilles tendon  ESAOTE MyLab70 Prevalence of US abnormalities 95% enthesophytes  and 26.3% erosions in SpA
2010 (29) 21 HC  6-18 MHz Thickness at the enthesis Thickness of the anechoic layer not different between
    GS  SpA and HC 
De Miguel 68 early SpA Achilles tendon GE Logiq 9 To evaluate the persistence, US erosions: US 7.4% of entheses 
2011 (30)   insertion 9-14 MHz increase or resolution of erosions 3D 9.6% of entheses 
  bone erosions 8-11 MHz Reliability of US and 3D US Erosions significantly associated with CRP, SJC, TJC, 
  Followed every 6 2D and 3D GS and the concurrent validity tendon PD 
  months for a year   of Achilles enthesis erosions
    Intra and inter-reader reliability Inter-reader reliability: kappa 0.84 (2D) and 0.85 (3D)  
     Intra-reader reliability 0.84 (US) and 0.85 (3D)
De Miguel E.  113 early SpA Plantar fascia GE Logiq 9 (MASEI) Mean (sd) MASEI
2011 (2) (31) 24 controls with Achilles tendon 9-14 MHz Reference standard: clinical 22.20 (7.22) in AS 
 inflammatory patellar tendon GS and PD classification criteria 24.25 (10.71) in SpA 
 arthritis (distal and proximal)   19 (6) ReA
 57HC Quadricepital tendon   26.75 (27.93) IBD
  Brachial triceps tendon   19.56 (11.70) PsA
     12.26 (6.85)  Controls
  calcifications, erosions, 
  tendon structure,    Mean (SD) MASEI 23.36 (11.40) in cases, 12.26 (6.85)
  tendon thickness,    in the non-inflammatory controls (p<0.001), 16.04 (9.94) 
  bursa, PD   in the inflammatory controls  (p<0.01)
  MASEI 
Feydy A. 51 SpA Achilles tendon Toshiba Aplio Performance of MRI and US of No differences between patients and controls
2012 (32) 24 controls Plantar fascia 7-15 MHz the heel to distinguish SpA from Abnormalities more frequent in painful heels : 
 with mechanical  GS and PD controls and SpA with and 58% vs. 17% (p<0.001) 
 back pain  echostructure  without enthesopathy.  Achilles tendon thickening of >5.29 in symptomatic
  abnormalities,    patients: 31% vs. 10% (p=0.033)
  retrocalcaneal    Mean thickness: 3.9 mm in symptomatic patients vs. 3.1
  bursitis, PD     mm in asymptomatic patients (p=0.007)
     PD not different between SpA and controls symptomatic  
     and asymptomatic
Gutierrez M. 46 SpA Trochanteric region ESAOTE MyLab 70 Prevalence of US abnormalities Enthesopathy: 40.5% in SpA vs. 29% in HC (p<0.0001)
2012  (33) 46 HC  thickening, 4-13 MHz  Calcifications: 33.9% in SpA vs. 28.7% in HC
  calcifications, bone  GS and PD  Enthesophytes: 25% in SpA vs. 20% in HC
  erosions,    Thickness: 18.7% in SpA vs. 43.7% in HC
  enthesophytes,   Erosions: 11.6% in SpA vs. 7.5% in HC 
  bursitis, PD   Bursitis 10.7% in SpA
     PD 1% in SpA
Hodgson R. 25 Spa Achilles tendon GE logiq 9 Prevalence of US abnormalities GS abnormalities: 76%
2011 (34) with painful  14 MHz  detected through MRI, ultrashort PD: 56%
 Achilles tendon   GS and PD echo time MRI and US Flogositic signs seen more often by ultrashort echo
 10 HC     time MRI than US and MRI
Merot O. 16 SpA  MASEI (conventional  - Reliability of 3D US vs. US for Intra-reader reliability:
2013  (35)  US  vs. 3D)    the scoring enthesitis in SpA  ICC US: 0.776 (0.471-0.916) and 0.96 (0.892-0.986)
     ICC 3D US: 0.796 (0.498-0.921) and 0.703 (0.325-0.886
    Intra and inter-reader reliability Inter-reader reliability
     ICC  US: 0.641 (0.221-0.859) 
     ICC 3D US:  0.776 (0.471-0.916)
     Correlation US-3D US:
     ICC 0.705 (0.329-0.887) 
Mouterde G. 14 SpA mildly Selected enthesis  ESAOTE MyLAb 70 Responsiveness to change  Decease of CEUS score from baseline to T1
2014 (36) active followed with doubtful PD  10-18 MHz of CEUS PD  (0.86 to 1.23; p=0.03)
 after stopping on conventional US 3-9 MHz  Increase after stopping NSAIDs (1.03 p>0.05) 
 NSAIDS and (more frequently 
 after reassuming common extensor 
 NSAIDs  tendon)  
Queiro  15 SAPHO Common extensor GE Logiq5 Prevalence of US abnormalities  7/15 (47%) at least an abnormality
2012 (42) 30 HC  and flexor tendons, 7-12 MHz   15% in SAPHO vs. 4.8% in HC of entheses involved
  quadricipital tendon, GS and PD  (p<0.01) 
  patellar tendon 
  (proximal and distal), 
  Achilles tendon and 
  plantar fascia 
Ruta S. 60 Spa without Quadriceps tendon ESAOTE MyLab 60 Prevalence of subclinical 331/544 (60.8%) of asymptomatic entheses showed at
2011 (37) clinical and patellar tendon 6-18 MHz enthesitis least one US abnormality 
 enthesitis (proximal and distal) 
 60 RA
 30 HC     
       
Table V continues on next page
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of US abnormalities in different SpA 
populations, providing in most cases 
data from control populations of healthy 
subjects or patients with other inflam-
matory pathology. These studies con-
firmed in general a higher prevalence of 
abnormalities in patients compared to 
controls, and the more frequent detec-
tion of abnormalities by US compared 
to clinical examination. However, re-
cent studies (22) involving patients with 
PsA, reported a low prevalence of sub-
clinical enthesitis (4%). US and clinical 
examination showed a poor agreement 
in detecting the presence of entheseal 
involvement, while the agreement in ex-
cluding enthesitis was good. The poten-
tial of US in excluding rather than de-
tecting enthesitis has been explored also 
in the context of fibromyalgia, to distin-
guish non-specific tenderness from evi-
dent entheseal involvement, confirming 
a higher prevalence of US alterations in 
patients with PsA  (26). 
The validity of US in the assessment of 
entheses was confirmed in these stud-
ies, with US findings being significant-
ly related to acute phase reactants and 
clinical measures of disease activity.
Several studies focused on the applica-
tion of US in subgroups of patients at 
risk of developing SpA, in particular 
the majority of studies were based on 
patients with psoriasis. In this context, 
US alterations were detected more fre-
quently in psoriatic subjects than in 
healthy controls, although the preva-
lence of US abnormalities was in gen-
eral still higher in patients with diag-
nosed PsA. In this cathegory, US find-
ings have also shown a prognostic val-
ue in the prediction of the subsequent 
development of clinically detectable 
arthropathy, with quadricipital tendon 
thickness being an independent predic-
tor for a clinical diagnosis of arthritis 
(46). The GUESS and MASEI scores 
were applied in this field as well.
Data deriving from cross-sectional 
studies confirm what had emerged in 
the previous literature on the applica-
tion of US in SpA. However, the preva-
lence of cross-sectional design leads 
to limited available information on the 
value of US in treatment monitoring, 
responsiveness to change and diagnos-
tic potential. In particular, only a minor-
ity of the included studies examined the 
value of entheseal US for diagnostic 
purposes. This has probably been influ-
enced by the absence of a reliable refer-
ence standard to define enthesitis, with 
difficulties in performing histological 
assessments and with several limita-
tions in the evaluation performed both 
clinically and by imaging techniques, 
with conventional radiography and 
MRI lacking satisfactory performance 
for these structures (57). A single study 
investigated the diagnostic utility of US 
in a real clinical practice setting (51), 
examining consecutive patients pre-
senting with clinical suspicion of SpA 
and using the clinical diagnosis after 
two years as reference standard and 
demonstrating good values of sensitivi-
ty, specificity and positive and negative 
likelihood ratios.
A limited number of studies report in-
formation on responsiveness to change, 
however, entheseal US has confirmed 
significant changes after the modifica-
tion of effective treatment.
A minority of studies focused on US 
techniques which so far have not been 
introduced in common clinical practice, 
such as 3D US, contrast-enhanced US 
and elastosonography. The emerging 
data suggest a possible role of 3D US 
in the assessment of entheses, the ap-
plication of CEUS in case of doubtful 
US involvement, and elastosonography 
to identify the most involved tendon 
region.
The overview of the literature confirms 
that a significant amount of informa-
tion has accumulated in the field of 
the application of US in SpA, although 
the absence of uniform definitions for 
US enthesopathy have led to a general 
dishomogeneity of the results. The cre-
ation of a provisional definition of en-
Study Population  Region of interest US equipment Outcome Results
Wiell C. 12 SpA Achilles tendon GE Logiq 9 Prevelence of abnormalities in Entesophytes more frequent in SpA
2013 (38) 15 HC  9-14 MHz painful Achilles tendon in SpA Intratendineous changes more frequent in SpA  
  thickness,  GS and PD vs. HC
  calcifications, 
  erosions, 
  enthesophytes, PD 
Zytoon A . 38 SpA with elbow HDI 3000 ATL Prevalence of US abnormalities  100% loss of pattern
2014 (39) elbow  5-12 MHz  84.2% peritendineous oedema 
 enthesopathy    100% tendon thickening 
 10 HC     84% intratendineous defects 
     52.6% calcifications 
     13% erosions 
Aydin S. SpA  Knee enthesopathy -  Prevalence of US abnormalities Enthesitis in 86% of patients
2013 (40)   (8 entheseal sites)   Correlation with clinical Clinical enthesitis was associated with more 
    examination hypoechogenicity (16 vs. 4%, p=0.007) and thickening 
     (16 vs. 6%, p=0.03).
     Agreement between clinical assessment and US was very  
     low: kappa (0.06-0.18) 
     No correlations between the MRI and US scores 
     (rho = 0.059) 
Falcao S. 66 early SpA Achilles tendon  Conventional US Prevalence of US bursitis  67.4% bursitis in SpA, 58.7%in  HC, 21.7 RA (p<0.01)
2013 (41) 46 controls bursa and 3D 
 (HC and RA) 
AS: ankylosing spondylitis; PsA: psoriatic arthritis; HC: healthy controls; GS: grey scale; PD: power Doppler; US: ultrasonography; CRP: C-reactive protein; ESR: erythrosedi-
mentation rate; MASEI: Madrid Sonographic Enthesitis Index;  GUESS: Glasgow Ultrasound Enthesitis Scoring System. 
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thesitis will have an impact on upcom-
ing research leading to more generalis-
able data. So far, US has shown to be 
a reliable tool, able to distinguish cases 
from controls in entheses in patients 
with SpA, with promising utility in the 
field of differential diagnosis and moni-
toring response to treatment. A larger 
number of prospective studies evaluat-
ing its potential in realistic clinical set-
tings will help translate its application 
into widespread clinical practice. 
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